ShRNA-based POLD2 expression knockdown sensitizes glioblastoma to DNA-Damaging therapeutics.
Xu Q, Hu C, Zhu Y, Wang K, Lal B, Li L, Tang J, Wei S, Huang G, Xia S, Lv S, Laterra J, Jiang Y, Li Y.
Xu Q, et al.
Cancer Lett. 2020 Jul 10;482:126-135. doi: 10.1016/j.canlet.2020.01.011. Epub 2020 Jan 16.
Cancer Lett. 2020.
PMID: 31954770
Free PMC article.